SynthesisFrontiers in endocrinology2025

Comparative effects of SGLT2 inhibitors and incretin-based therapies on dementia risk in type 2 diabetes: a systematic review and meta-analysis.

Kirim Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.